Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZONIC study of azosemide versus furosemide in chronic heart failure
KCT0012639Phase 4Completed
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azosemide, furosemide in chronic heart failure (CHF), sponsored by Samjin Pharmaceutical Co., Ltd.. Started Dec 2019; status: completed.
02
Drugs
azosemidefurosemide
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on KCT0012639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012639.